340 related articles for article (PubMed ID: 36738311)
1. Machine learning predictive performance evaluation of conventional and fuzzy radiomics in clinical cancer imaging cohorts.
Grahovac M; Spielvogel CP; Krajnc D; Ecsedi B; Traub-Weidinger T; Rasul S; Kluge K; Zhao M; Li X; Hacker M; Haug A; Papp L
Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1607-1620. PubMed ID: 36738311
[TBL] [Abstract][Full Text] [Related]
2. An [
Meng N; Feng P; Yu X; Wu Y; Fu F; Li Z; Luo Y; Tan H; Yuan J; Yang Y; Wang Z; Wang M
Eur Radiol; 2024 Jan; 34(1):318-329. PubMed ID: 37530809
[TBL] [Abstract][Full Text] [Related]
3. Machine learning-based analysis of [
Cysouw MCF; Jansen BHE; van de Brug T; Oprea-Lager DE; Pfaehler E; de Vries BM; van Moorselaar RJA; Hoekstra OS; Vis AN; Boellaard R
Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):340-349. PubMed ID: 32737518
[TBL] [Abstract][Full Text] [Related]
4. Use of radiomics based on
Zhou Y; Ma XL; Zhang T; Wang J; Zhang T; Tian R
Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2904-2913. PubMed ID: 33547553
[TBL] [Abstract][Full Text] [Related]
5. Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [
Papp L; Spielvogel CP; Grubmüller B; Grahovac M; Krajnc D; Ecsedi B; Sareshgi RAM; Mohamad D; Hamboeck M; Rausch I; Mitterhauser M; Wadsak W; Haug AR; Kenner L; Mazal P; Susani M; Hartenbach S; Baltzer P; Helbich TH; Kramer G; Shariat SF; Beyer T; Hartenbach M; Hacker M
Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1795-1805. PubMed ID: 33341915
[TBL] [Abstract][Full Text] [Related]
6. A Machine Learning Model Based on PET/CT Radiomics and Clinical Characteristics Predicts Tumor Immune Profiles in Non-Small Cell Lung Cancer: A Retrospective Multicohort Study.
Tong H; Sun J; Fang J; Zhang M; Liu H; Xia R; Zhou W; Liu K; Chen X
Front Immunol; 2022; 13():859323. PubMed ID: 35572597
[TBL] [Abstract][Full Text] [Related]
7. Error mitigation enables PET radiomic cancer characterization on quantum computers.
Moradi S; Spielvogel C; Krajnc D; Brandner C; Hillmich S; Wille R; Traub-Weidinger T; Li X; Hacker M; Drexler W; Papp L
Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):3826-3837. PubMed ID: 37540237
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive monitoring of allograft rejection in a rat lung transplant model: Application of machine learning-based
Tian D; Shiiya H; Takahashi M; Terasaki Y; Urushiyama H; Shinozaki-Ushiku A; Yan HJ; Sato M; Nakajima J
J Heart Lung Transplant; 2022 Jun; 41(6):722-731. PubMed ID: 35430149
[TBL] [Abstract][Full Text] [Related]
9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
10. Machine learning-based radiomics for multiple primary prostate cancer biological characteristics prediction with
Yao F; Bian S; Zhu D; Yuan Y; Pan K; Pan Z; Feng X; Tang K; Yang Y
Radiol Med; 2022 Oct; 127(10):1170-1178. PubMed ID: 36018488
[TBL] [Abstract][Full Text] [Related]
11. The role of [
Basso Dias A; Mirshahvalad SA; Ortega C; Perlis N; Berlin A; van der Kwast T; Ghai S; Jhaveri K; Metser U; Haider M; Avery L; Veit-Haibach P
Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):2167-2176. PubMed ID: 36809425
[TBL] [Abstract][Full Text] [Related]
12. Multi-lesion radiomics of PET/CT for non-invasive survival stratification and histologic tumor risk profiling in patients with lung adenocarcinoma.
Zhao M; Kluge K; Papp L; Grahovac M; Yang S; Jiang C; Krajnc D; Spielvogel CP; Ecsedi B; Haug A; Wang S; Hacker M; Zhang W; Li X
Eur Radiol; 2022 Oct; 32(10):7056-7067. PubMed ID: 35896836
[TBL] [Abstract][Full Text] [Related]
13. Molecular subtype classification of breast cancer using established radiomic signature models based on
Liu J; Bian H; Zhang Y; Gao Y; Yin G; Wang Z; Li X; Ma W; Xu W
Front Biosci (Landmark Ed); 2021 Aug; 26(9):475-484. PubMed ID: 34590460
[No Abstract] [Full Text] [Related]
14.
Li H; Xu C; Xin B; Zheng C; Zhao Y; Hao K; Wang Q; Wahl RL; Wang X; Zhou Y
Theranostics; 2019; 9(16):4730-4739. PubMed ID: 31367253
[No Abstract] [Full Text] [Related]
15. Development and validation of an
Wang H; Zhao S; Li L; Tian R
Eur Radiol; 2020 Oct; 30(10):5578-5587. PubMed ID: 32435928
[TBL] [Abstract][Full Text] [Related]
16. [
Ferreira M; Lovinfosse P; Hermesse J; Decuypere M; Rousseau C; Lucia F; Schick U; Reinhold C; Robin P; Hatt M; Visvikis D; Bernard C; Leijenaar RTH; Kridelka F; Lambin P; Meyer PE; Hustinx R
Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3432-3443. PubMed ID: 33772334
[TBL] [Abstract][Full Text] [Related]
17. Integrated CT Radiomics Features Could Enhance the Efficacy of
Zhou W; Huang Q; Wen J; Li M; Zhu Y; Liu Y; Dai Y; Guan Y; Zhou Z; Hua T
Front Oncol; 2021; 11():772703. PubMed ID: 34869011
[TBL] [Abstract][Full Text] [Related]
18. Accurate Tumor Delineation
Sepehri S; Tankyevych O; Iantsen A; Visvikis D; Hatt M; Cheze Le Rest C
Front Oncol; 2021; 11():726865. PubMed ID: 34733779
[TBL] [Abstract][Full Text] [Related]
19. Preoperative prediction of mediastinal lymph node metastasis in non-small cell lung cancer based on
Huang Y; Jiang X; Xu H; Zhang D; Liu LN; Xia YX; Xu DK; Wu HJ; Cheng G; Shi YH
Clin Radiol; 2023 Jan; 78(1):8-17. PubMed ID: 36192203
[TBL] [Abstract][Full Text] [Related]
20. Value of pre-therapy
Zhang J; Zhao X; Zhao Y; Zhang J; Zhang Z; Wang J; Wang Y; Dai M; Han J
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1137-1146. PubMed ID: 31728587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]